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he p160–Rho-associated coiled-coil–containing protein
kinase (ROCK) is identiﬁed as a new centrosomal
component. Using immunoﬂuorescence with a variety
of p160ROCK antibodies, immuno EM, and depletion with
RNA interference, p160ROCK is principally bound to the
mother centriole (MC) and an intercentriolar linker. Inhibition
of p160ROCK provoked centrosome splitting in G1 with
the MC, which is normally positioned at the cell center and
T
 
shows little motion during G1, displaying wide excursions
around the cell periphery, similar to its migration toward
the midbody during cytokinesis. p160ROCK inhibition late
after anaphase in mitosis triggered MC migration to the
midbody followed by completion of cell division. Thus,
p160ROCK is required for centrosome positioning and
centrosome-dependent exit from mitosis.
 
Introduction
 
Centrosomes, the major microtubule-organizing centers in
mammalian cells, are complex organelles, comprising two
centrioles associated by the pericentriolar matrix. Centro-
somes are involved in both cell motility and cell division. In
migrating cells, centrosome positioning is involved in the
stabilization of pseudopodia (Ueda et al., 1997). Cen-
trosomes are subject to important structural modifications
during the cell cycle, including duplication, maturation, and
separation (for reviews see Andersen, 1999; Tassin and
Bornens, 1999; Hinchcliffe and Sluder, 2001).
Recent studies have revealed differential behavior of the
two centrioles (Piel et al., 2000, 2001). In G1 cells, although
the mother centriole (MC) stays close to the cell center, the
daughter centriole (DC) shows wide excursions throughout
the cell cytoplasm. The MC is responsible for the formation
of a microtubule aster, and this is probably the basis for its
positioning at the cell center (Holy et al., 1997). In con-
trast, the DC nucleates microtubules that are released and
migrate toward the cell periphery (Piel et al., 2000). This
combination of a centered, microtubule-anchoring MC
and of a mobile, microtubule-releasing DC could be impor-
tant for directional cell motility. In addition, centrosome or-
ganization and motions are apparently crucial for the com-
pletion of cytokinesis. The separation of daughter cells at the
end of mitosis is apparently controlled by a migration of
the MC toward the midbody (Piel et al., 2001).
Some of the factors important for the control of cen-
trosome organization and centrosome behavior have been
identified. The ability of the MC to generate microtubule
asters is attributable to specific features of its associated peri-
centriolar material (PCM),* which contains the microtubule-
anchoring protein ninein (Mogensen et al., 2000; Piel et al.,
2000). The relative position of the two centrioles and the
centrosome movements within cells are dependent on both
microtubule and microfilaments organization (Euteneuer
and Schliwa, 1985; Schliwa et al., 1999). Centrosome cohesion
is affected by the kinase Nek2 (Fry et al., 1998a,b; Mayor et
al., 2000; Meraldi and Nigg, 2001). The identification of
additional centrosome regulators may arise from an inventory
of the centrosome components. To identify PCM compo-
nents, we have previously developed monoclonal antibodies
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directed against isolated centrosomes. One of these antibodies,
mAb 6C6, reacted with the centrosome or microtubule-
organizing centers in a wide variety of animal and plant cells
(Chevrier et al., 1992). Here, using this antibody we have
identified the Rho-dependent protein kinase p160ROCK as
a PCM component. p160ROCK is important for actin or-
ganization and coordinated microtubule regulations (Ish-
izaki et al., 1996, 1997; Matsui et al., 1996; Narumiya et al.,
1997; Hirose et al., 1998; Amano et al., 2000; Kosako et al.,
2000). We report that p160ROCK is also required for cen-
triole positioning and is essential for MC movement toward
the midpiece in late telophase, hence for signaling the end of
cytokinesis.
 
Results
 
Centrosomal localization of p160 ROCK
 
In a screen of an MDBK cDNA expression library with mAb
6C6, one positive clone (clone N) coded for a 438 amino
acid polypeptide showing 98% sequence homology with a
peptide sequence belonging to the kinase, p160ROCK (Fig.
1 A). This data raised the possibility that p160ROCK was
present on centrosomes. To test this possibility, protein N
was expressed in bacteria and used to generate a polyclonal
antibody (antibody N). Epitopes recognized by the antibody
were then mapped using peptide array analysis (SPOT anal-
ysis) (Fig. 1 B). Nine peptide clusters reacted with the anti-
body N on SPOT membranes (peptides N1–N9). Five
peptide-specific antibodies were further derived from the
antibody N using affinity chromatography with peptides
N2, N3, N5, N6, and N7, respectively (Fig. 1 C). On West-
ern blots of total protein extracts from MDBK cells, these
antibodies reacted with a single 160-kD band corresponding
to p160ROCK (Fig. 2 A). The same antibodies reacted with
a 160-kD band on immunoblots of centrosomal fractions
and also reacted with an additional protein of slightly
smaller apparent molecular weight (Fig. 2 A). This latter
protein may be a proteolytic product of p160ROCK gener-
ated during centrosome preparation or a specific centro-
somal variant of p160ROCK whose structure remains to
be determined. The antibodies also brightly stained cen-
trosomes in different cell lines including MDBK and HeLa
cells. The staining was concentrated on the MC and on an
apparent linker structure between the centrioles (Fig. 2 B).
Similar centrosome staining was observed with other
p160ROCK antibodies, including commercial antibodies,
ROCK-1 (C-19) antibody, and an affinity purified antibody
raised against peptide N6-stained centrosomes (unpublished
data). Immuno EM examination of centrosomes isolated
from human KE37 lymphoblastic cells also showed intense
staining of the intercentriolar linker (Fig. 2 C). The differ-
ence in labeling between the mother and DC was not clear
on immuno EM images may be due to some degree of PCM
dispersion during centrosome purification and absence of
signal summation in centrosome sections.
We used RNA interference to test directly whether the
centrosomal staining observed with p160ROCK antibodies
corresponded to p160ROCK. HeLa cells were transfected
with four different silencing RNA (siRNA) oligoduplexes
corresponding to different coding regions of the p160ROCK
 
mRNA. Immunoblot analysis of total cell extracts showed
p160ROCK depletion in cells exposed to siRNA (Fig. 2 D).
In the presence of each one of the siRNA oligoduplexes, a
substantial proportion of cells showed nuclear condensation
and major disturbances of the microtubule cytoskeleton.
These cells were not further analyzed. Among cells with ap-
parently normal nuclei and microtubule content, cells with a
conspicuously abnormal morphology, typical of p160ROCK
inhibition (Hirose et al., 1998; Tominaga et al., 1998) were
observed. Such cells have an irregular or elongated shape
with characteristic cell extensions (Fig. 2 E; see Fig. 4, A and
B). For each one of the four siRNA duplexes, a total of
 
 
 
100 cells showing abnormal morphology were examined
for centrosome staining with p160ROCK antibody. This
centrosome staining was uniformly absent. Cells transfected
with mutated siRNA duplexes had normal morphology and
always showed centrosome staining with p160ROCK anti-
body as nontransfected control cells (unpublished data).
Figure 1. Structure of clone N. (A) Schematic representation of 
p160ROCK and clone N. p160ROCK (sequence data available from 
GenBank/EMBL/DDBJ under accession no. U43195) is a 160-kD 
protein serine/threonine kinase containing a kinase domain (KD), a 
long amphipathic  -helix capable of forming a coiled-coil structure 
(CCD) containing a Rho binding domain (RBD), the pleckstrin 
homology domain (PHI-V, VI) split by a cysteine-rich zinc finger 
(CRD); clone N (sequence data available from GenBank/EMBL/
DDBJ under accession no. AY025529) coded for a protein fragment 
(protein N) corresponding to amino acids 594–1028. The positions 
of the nine epitopes recognized by polyclonal antibody directed 
against protein N (see B) are indicated. (B) Peptide SPOT analysis of 
the epitopes recognized by protein N polyclonal antibody showing 
nine positive peptide clusters (1–9). The sequences of the nine 
corresponding epitope peptides are shown below (N1 to N9). 
(C) Peptide SPOT analysis of the affinity purified N6 antibody. The 
affinity purified antibody reacted exclusively with peptide N6. 
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These results yield compelling evidence for a centrosomal lo-
calization of p160ROCK.
 
Effect of p160ROCK inhibition on centriole splitting
 
The centrosomal localization of p160ROCK raised the pos-
sibility that p160ROCK activity could affect centrosome
structure or activity. We used several independent methods
of p160ROCK inhibition to test this possibility.
We first examined the effect of the p160ROCK inhibitor
Y-27632 (Uehata et al., 1997) in HeLa cells stably express-
ing green fluorescent protein (GFP) centrin stained with an-
tibody N6 (Fig. 3). In control cells, centrosome staining was
observed at all phases of the cell cycle. In late G2 cells, both
centrosomes were stained, and the specific labeling of the
linker structure evident in G1 was not visible (Fig. 3, d–f).
Centriole staining with antibody N6 persisted through mi-
tosis and cytokinesis. In the presence of Y-27632, the inter-
centriolar distance in G1 cells was generally conspicuously
increased compared with controls (Fig. 3, a–c and a
 
 
 
–c
 
 
 
).
When centrioles were split, the MC staining persisted, but
no distinct staining of a linker structure was detectable (Fig.
3, a
 
 
 
–c
 
 
 
). Y-27632 had no apparent influence on centrosome
staining in G2, metaphase, or anaphase cells. In telophase
cells, treatment with Y-27632 induced a concentration of
p160ROCK labeling in the cell midzone (Fig. 3, j
 
 
 
–o
 
 
 
).
The intercentriolar distance increased in cells treated with
10 
 
 
 
M Y-27632 (Fig. 4 A, f and h), but the drug effect was
maximal with 100 
 
 
 
M Y-27632 (Fig. 4 A, j and l). Treated
cells tended to elongate microtubules to form parallel bun-
dles (Fig. 4 A, e and i), whereas actin stress fibers disap-
peared (Fig. 4 A, g and k). After drug withdrawal, micro-
filament and microtubule networks and the cell shape
apparently went back to normal within 2–4 h (Fig. 4 A, m
and o). In contrast, the intercentriolar distance remained el-
evated (Fig. 4 A, n and p).
When cells were transfected with the p160ROCK mutant
KDIA, which acts as a dominant negative (Ishizaki et al.,
1997), similar morphology changes and centrosome split-
ting (Fig. 4 B) were observed as in Y-27632–treated cells.
Similar changes were also observed with siRNAs (Fig. 2 E).
In quantitative study of p160ROCK inhibition, the av-
erage intercentriolar distance increased threefold in the
presence of 100 
 
 
 
M Y-27632 (Fig. 5 A) with a half-maxi-
Figure 2. Centrosomal localization of 
p160ROCK. (A) Immunoblot analysis of 
total protein extracts from MDBK cells 
(T) and purified calf thymus centrosomes 
(C) using antibodies N, N2, N3, N5, N6, 
and N7. In total cell extracts, the peptide-
purified antibodies reacted with a single 
160-kD protein corresponding to 
p160ROCK. In centrosomal fractions, 
the same antibodies also stained a 
slightly lower molecular weight protein 
that may be a proteolytic product of 
p160ROCK or a centrosomal variant of 
this protein. (B) Immunostaining of HeLa 
GFP-centrin cells (a) with N6 antibody 
(b). The MC and DC were identified 
based on the centrin signal by conven-
tional fluorescence microscopy examina-
tion of the cells. On visual examination, 
the MC shows distinctly stronger centrin 
signal than the DC (Piel et al., 2000). 
This difference is still visible although of-
ten less striking in confocal images. Bar, 1 
 m. (C) Immuno EM localization of 
p160ROCK with polyclonal antibody N6 
in isolated KE 37 centrosomes showing 
staining of the PCM, including the 
intercentriolar linker. Controls run with 
secondary antibody alone showed a 
complete absence of staining (unpublished 
data). Bar, 1  m. (D) Silencing of 
p160ROCK: immunoblot analysis of 
p160ROCK in total cell extracts from 
either control HeLa cells or from HeLa 
cells transfected with siRNA n 3 (72 h 
after transfection), using p160ROCK 
antibody N6 as a primary antibody. 
Equal amounts of total cell protein from 
control and transfected cells were loaded as estimated from Coomassie blue gels (unpublished data). (E) Centrosome staining in HeLa GFP-centrin 
cells transfected with siRNA: cells were transfected with siRNA n 3. (a) Centriole visualization with GFP-centrin; (b) centriole staining with 
p160ROCK N6 antibody; (c) microtubule staining with anti– -tubulin antibody. Changes in cell shape were used as a criteria for p160ROCK 
depletion. The figure is centered on a cell with abnormal shape, showing absence of centrosome staining with p160ROCK antibodies. The 
cell was surrounded by cells of normal shape, showing p160ROCK centrosome staining. Bar, 5  m. 
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mal effect within 45 min after cell exposure to the drug.
After drug withdrawal, no significant changes in the aver-
age intercentriolar distance were observed within 4 h (Fig.
5 B). Cell shape changes were quantified, using as an index
the ratio of the cell perimeter to the cell surface (Fig. 5 C).
When cells were treated for 1.5 h with 100 
 
 
 
M Y-27632,
the perimeter to surface ratio increased significantly in the
presence of the drug but went back to control values
within 2 h after drug withdrawal, whereas centriole separa-
tion persisted (Fig. 5, B and C).
Increases of the perimeter to surface ratio and of the in-
tercentriolar distance were also observed in cells trans-
fected with the KDIA construct or with siRNA (Fig. 5, D
and E). Thus, similar centrosome splitting was observed
using three independent methods for p160ROCK inhibi-
tion.
 
Effect of p160ROCK inhibition on centrosome positioning
 
We used videomicroscopy to investigate the effect of
p160ROCK inhibition on centriole positioning. Centrioles
display little motion during the S and G2 phases of the cell
cycle. In contrast, centrioles can show important motion in
G1 when the DC transiently shows excursion through the
cell cytoplasm in migrating cells, and in late telophase, when
 
the MC leaves its central position and migrates toward the
midbody (Piel et al., 2001). Cell exposure to 100 
 
 
 
M
Y-27632 did not change centriole behavior in S or G2 cells
(unpublished data). In late anaphase cells exposed to the
drug, the MC movement toward the midbody remained of
normal amplitude and duration (Fig. 6). In contrast, after
abscission and exit from mitosis major changes affected the
MC behavior, which instead of being almost immobile and
positioned near to the cell center as in control cells displayed
persistent motion (Fig. 6, A and B), often being located near
the cell periphery. Although in control cells both centrioles
remained in close vicinity, except for short periods of time
(Fig. 6 A, 03:24 and 03:28, and B), in treated cells the two
centrioles were often widely separated (Fig. 6, A and B). Af-
ter drug withdrawal, the MC behavior was back to normal
within 2 h, and the organelle slowly relocated to the cell cen-
ter. However, the two centrioles usually failed to cluster, and
the intercentriolar distance remained elevated (Fig. 6 B).
In G1 cells treated with Y-27632 after cytokinesis, the
MC left its normal central position within a few minutes af-
ter addition of the drug, moving away from the DC and un-
dergoing erratic motion. The MC frequently moved back
and forth along the plasma membrane (Fig. 7 B). In some
cases, it circled the nucleus (Fig. 7 B).
Figure 3. Cell cycle changes in the 
distribution of p160ROCK. Immunoflu-
orescence of HeLa GFP-centrin cells 
with N6 antibody. Centrioles are visible 
as green dots (a, a’, d, d’, g, g’, j, j’, m, 
and m’). The red staining corresponds to 
N6 antibody staining (b, b’, e, e’, h, h’, 
k, k’, n, and n’). Merged images: c, c, f, 
f’, i, i’, l, l’, o, and o’. Cells are shown in 
G1 phase (a–c and a’–c’), G2 phase (d–e 
and d’–e’), metaphase (M; g–i and g’–i’), 
late anaphase through early telophase 
(A/T; j–l and j’–l’), and cytokinesis (CK; 
m–o and m’–o’) in the absence (a–o) or 
presence (a’–o’) of the p160ROCK 
inhibitor Y-27632. The MC and DC 
were identified as in Fig. 2. Bar, 5  m. 
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In the presence of nocodazole, the effect of Y-27632 on
the MC movement was inhibited (Fig. 8). In contrast, a
30-min treatment with cytochalasin D (CD) preceding
Y-27632 addition did not modify the MC behavior. Thus, the
MC movements induced by Y-27632 were microtubule de-
pendent but actin independent as reported previously for the
telophase MC movement (Piel et al., 2001). Cytochalasin
treatment suppressed the DC motion (Fig. 8) as previously
observed (Piel et al., 2000).
Centriole movements were also examined in cells trans-
fected with KDIA mutant. In transfected G1 cells, MCs
showed the same erratic motions around the cells as in cells
treated with Y-27632 (unpublished data).
 
p160ROCK inhibition triggers MC migration toward 
the midpiece and subsequent completion of cytokinesis 
in postanaphase cells
 
After our observations of centriole separation and MC de-
localization after p160ROCK inhibition, we wondered
whether p160ROCK inhibition could trigger MC migration
in the midbody in postanaphase cells. To test this possibil-
ity, postanaphase cells isolated by mitotic shake off were
treated with Y-27632 1 h after replating, and the percentage
of pairs of daughter cells with a centriole in the midbody re-
gion bridge was monitored over time (Fig. 9 A). The
percentage of cells linked by a cytoplasmic bridge was de-
termined at the same time points (Fig. 9 B). Centriole
Figure 4. Centrosome splitting by p160ROCK 
inhibition. (A) Immunostaining of HeLa GFP-
centrin cells with monoclonal anti– -tubulin 
antibody or phalloidin-rhodamine. Untreated 
cells (a–d); cells treated for 1.5 h with 10  M 
Y-27362 (e–h); cells treated with 100  M 
Y-27362 for 1.5 h (i–l); cells treated with 100 
 M Y-27362 for 1.5 h (m–p) examined 4 h after 
withdrawal of the drug. Exposure to the drug 
caused cell shape changes, stress fiber 
disruption, and centrosome splitting. Centrosome 
splitting persisted after drug withdrawal. Bar, 5 
 m. (B) Immunostaining of HeLa GFP-centrin 
cells transfected with cMyc-tagged p160ROCK 
dominant negative KDIA construct. Cells were 
examined 24 h after transfection. GFP-centrin 
(a and d); tubulin staining (b); phalloidin-
rhodamine staining (e); c-Myc staining (c and f). 
c-Myc–positive cells showed abnormal shape, 
stress fiber disruption, and centrosome splitting 
as Y-27632–treated cells. Bar, 5  m. 
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migration in the midbody occurred prematurely in treated
cells compared with controls with a frequency maximum at
30 min after exposure to the drug compared with 1.5–2 h in
controls (Fig. 9 A). This maximum was up to 60% in drug-
treated cell pairs compared with 
 
 
 
15% in control cell pairs.
Thus, there was a striking synchronization effect of drug
treatment on MC localization in the midbody. Additionally,
the proportion of cells linked by a cytoplasmic bridge
dropped prematurely in drug-treated cells compared with
control cells and then continued to diminish more rapidly
over time (Fig. 9 B), indicating that the drug-induced MC
migration to the midbody was followed by abscission.
 
Discussion
 
Centrosomal localization of p160ROCK
 
Our data show association of p160ROCK with the PCM
surrounding the MC and with an intercentriolar linker
structure in G1 cells. Apparently, the DC recruits
p160ROCK during duplication. Several proteins show tran-
sient or permanent-specific association with the MC includ-
ing ninein (Mogensen et al., 2000), cenexin, or ODF2
(Lange and Gull, 1995; Nakagawa et al., 2001) and epsilon
tubulin (Chang and Stearns, 2000). Our data identify
p160ROCK as an additional marker of the MC.
On EM images of isolated centrosomes, the MCs and
DCs are bridged by a distinct linker structure (Bornens et
al., 1987). However, markers of this structure in intact
cells have been lacking, and this has lead to doubts con-
cerning the existence of an intercentriolar linkage in vivo
(Jean et al., 1999). Our data provide strong evidence for a
localization of p160ROCK on the linker both in vitro and
in vivo. Therefore, the enzyme emerges as a new marker of
the linker in cells.
Figure 5. Quantitative analysis of intercentriolar distance and cell shape after p160ROCK inhibition. (A) Average intercentriolar distances 
in cells treated with 100  M Y-27632 for the indicated amounts of time. In each condition, the average intercentriolar distance was measured 
on a minimum number of 200 cells. SEMs are indicated. (B) Average intercentriolar distances in cells treated with 100  M Y-27632 for 1.5 h 
and then left to recover for the indicated amounts of time after drug withdrawal. Cell numbers and SEMs are as in A. (C) Perimeter to surface 
ratios in cells treated with 100  M Y-27632. Cells were treated with Y-27632 for the indicated amounts of time and then fixed and processed 
for analysis. In release experiments, cells were treated with 100  M Y-27632 for 90 min, then the drug was withdrawn, and at the indicated 
times after release from the drug, cells were fixed for subsequent analysis. In each condition, a minimum of 50 cells was examined. The 
perimeter to surface ratios showed little dispersion, and in some conditions SEMs were too small to be visible on the figure. (D) Average 
intercentriolar distances after p160ROCK inhibition with 100  M Y-27632, KDIA mutant, or siRNA as indicated. Cells were treated with 
Y-27632 for 4 h before analysis. KDIA-transfected cells were analyzed 24 h after transfection. For siRNA-treated cells, the analysis (48 h after 
transfection) concerns cells with extinct p160ROCK signal, normal nuclei, and assembled microtubule arrays. In each condition, the average 
intercentriolar distance was measured on a minimum number of 100 cells. SEMs are indicated. (E) Perimeter to surface ratios after p160ROCK 
inhibition. Conditions were as in D. 
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Effects of p160ROCK inhibition on centrosome 
structure and behavior
 
We find that p160ROCK inhibition triggers a permanent
centriole splitting in G1, persisting for hours after release
from inhibition when cells had recovered apparently normal
cytoskeleton, shape, and centriole motion. This is a strong
indication that p160ROCK inhibition causes changes in
centrosome structure, namely in the intercentriolar linker,
which seems to be an important determinant of the inter-
centriolar distance in G0-G1 cells (Komesli et al., 1989).
The apparent irreversibility of the centrosome splitting and
the disappearance of the p160ROCK staining of the inter-
centriolar area observed in G1 cell exposed to Y-27632 may
correspond to a complete linker disruption. However, the
loss of linker staining may be due to linker decondensation
with resulting dilution of the signal. We have observed that
even when centrioles are far apart in cells they seem to re-
main connected by a loose structure containing the matrix
protein AKAP 450 and centrin (unpublished data).
We also find that p160ROCK inhibition induces wide
MC excursions and relocation near the plasma membrane.
This effect is actin independent but microtubule dependent
and could involve a modification of microtubule dynamics
through the action of cytoplasmic p160ROCK on microtu-
bule dynamics or organization (unpublished data). Never-
theless, the centrosomal localization of a fraction or an iso-
form of p160ROCK suggests an action on the centrosome
itself. p160ROCK inhibition has no evident effect on mi-
crotubule nucleation (unpublished data) but may affect mi-
crotubule anchoring or the anchoring of the MC in the sur-
rounding cytoplasm.
The MC movements induced in G1 cells by p160ROCK
inhibition share close similarity with the normal telophase
movement of this centriole. Both movements involve wide
excursions and relocation of the MC at the cell periphery
and show similar differential sensitivity to nocodazole and
CD. Additionally, previous work has shown down-regula-
tion of Rho at the end of telophase (Kimura et al., 2000).
We now show that p160ROCK inhibition in postanaphase
cells is sufficient to trigger MC migration to the midpiece
and subsequent abscission. Together, these data strongly in-
dicate a central involvement of p160ROCK in triggering
centrosome-dependent exit of mitosis in cycling cells.
In this study, Y-27632 and the p160ROCK dominant
negative KDIA mutant had similar effects both inducing
centrosome splitting and wide MC motility. This similarity
in effects suggests a model in which centrosomal substrates
 
Figure 6 (continues on next page) 
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of p160ROCK are also binding partners of the enzyme.
Y-27632 is known to inhibit p160ROCK catalytic activity
by competing with ATP (Narumiya et al., 2000). In the pres-
ence of the drug, the unphosphorylated p160ROCK sub-
strate partners may remain bound on the enzyme and never
assemble into PCM structures. The same partners may be
trapped by the cytoplasmic KDIA mutant and, in the pres-
ence of this mutant, never reach the centrosome.
SiRNA duplexes had additional deleterious effect on cells
compared with Y-27632 or KDIA mutants, ultimately in-
ducing cell death. This probably results from the complete
elimination of all p160ROCK domains by RNA interfer-
ence, whereas the two other methods leave extensive parts of
the protein intact.
In conclusion, our data provide strong evidence that
p160ROCK activity is important for both centrosome orga-
nization and positioning of the centrioles and that it plays a
central role in centrosome-dependent cell exit of mitosis.
 
Materials and methods
 
Library screening and cDNA cloning and sequencing
 
A MDBK cDNA expression library (CLONTECH Laboratories, Inc.) was
screened with a previously characterized monoclonal antibody mAb 6C6
(Chevrier et al., 1992) using standard procedures.
 
Expression and purification of recombinant proteins
 
The clone N cDNA was subcloned into pGEX-4T3 vector (Amersham
Pharmacia Biotech). 
 
Escherichia coli
 
 BL21 cells were transformed with the
pGex construct. Fusion protein induction and purification were done using
standard methods.
 
Antibody production and purification
 
Immunization of rabbit was performed using 500 
 
 
 
g of purified N protein
emulsified in complete Freund’s adjuvant for the primary injection. Subse-
quent booster immunizations were performed on days 14, 28, 42, 56, and
70 using 500 
 
 
 
g of purified N protein emulsified in Freund’s incomplete
adjuvant. A test bleed demonstrated anticentrosome antibodies; preim-
mune serum was also collected and used for some control studies.
Serum was affinity purified against the purified N protein coupled to
sepharose 4B. The bound antibodies were eluted using 10 vol of 0.1 M
glycine, pH 2.5. The eluted antibodies were neutralized by the addition of
1 vol 1 M Tris HCl, pH 8.0, and the antibodies were dialysed against PBS
and concentrated for long term storage.
For anti–N peptide antibodies, serum was affinity purified against each
corresponding peptide coupled to sepharose 4B, and they were eluted as
described previously.
 
SPOT analysis
 
SPOT synthesis corresponding to N protein was performed according to
Frank (1992) with an Abimed ASP 222 automated SPOT robot. Peptide
sheet was permeabilized in ethanol bath, washed three times (10 min
each) with PBS 0.1% Tween 20 (PBST), and incubated 1 h at room temper-
ature with purified polyclonal antibody anti–N protein (1:5,000) or anti-
peptides N(1–9) (1:5,000) in PBST. After three washes (10 min each) in
PBST, the membrane was incubated with anti–rabbit antibody labeled with
HRP (1:5,000), washed three times as above, and developed using the
chemiluminescent ECL kit (Amersham Pharmacia Biotech).
 
RNA interference
 
To design target-specific siRNA duplexes, we selected four sequences of the
type AA(N19)dTdT from the ORFs of the p160ROCK mRNA (U43195) in or-
der to obtain a 21-nucleotide (nt) sense and 21-nt antisense strand with sym-
metric 2-nt overhangs of identical sequence as described by Harborth et al.
(2001). We used 2’ deoxythymidines instead of uridine residues in the 3
 
 
 
overhangs to enhance nuclease resistance. The selected sequences were
submitted to a BLAST search against the human genome sequence to ensure
that only p160ROCK gene of the human genome was targeted. 21-nt RNAs
were purchased from Dharmacon in deprotected and desalted form. The
siRNA sequence targeting p160ROCK were from position relative to the start
Figure 6. Videomicroscopy analysis of Y-27632 effect on centriole 
motility. Phase–contrast and fluorescence images of postmitotic 
and G1 Hela cells stably expressing GFP-centrin were recorded 
every 2 min. Cells were placed in a medium containing either 
DMSO (control cells) or Y-27632 as indicated. (A) The images on 
the left are extracted from movies. The corresponding time is 
indicated on the top left corner of each frame (h:min). An overlay 
of GFP signal (green) on the corresponding phase–contrast image 
is shown. The centrioles were spotted by hand with green dots to 
allow visualization at low magnification. The MC is the bigger 
one, indicated by a pink arrowhead before midbody rupture and 
a red arrowhead after midbody rupture. The DC is indicated by a 
gray arrowhead. Centriole trajectories are drawn on the right 
with the same color code. The cell margin at the beginning of the 
movie is indicated by a thin gray line. Thanks to the cytoplasmic 
fluorescence of the soluble GFP-centrin pool, the cell shape 
could be tracked automatically, and then the centroide of the 
cell was calculated for each plane. Centriole position is shown 
relatively to that centroide, which is thus the point 0 of the 
coordinates (indicated by C). Y-27632 was added at time 00:00. 
Bar, 10  m. (B) The intercentriolar distance and the centriolar 
speed are plotted over time (gray curve, DC speed). The four top 
graphs correspond to the cells shown in A. The two bottom 
graphs correspond to a release experiment: Y-27632 was added 
1 h before time 0, and then the cells were filmed during 1 h 
before the medium was replaced by Y-27632–free medium (three 
washings). In the case shown, the intercentriolar distance is 
elevated because the cell was elongated and the centrioles were 
on both sides of the cells when the drug was removed, resulting 
in an arrest of centriolar motion. The centrioles never clustered 
again after drug removal. 
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codon: n
 
 
 
1 
 
 
 
 566–584, n
 
 
 
2 
 
 
 
 639–657, n
 
 
 
3 
 
 
 
 1958–1976, and n
 
 
 
4 
 
 
 
2780–2798. As unspecific siRNA control, we used siRNA n
 
 
 
3 mutated on
three nucleotides. For annealing, 20 
 
 
 
M single-stranded 21-nt RNAs in an-
nealing buffer (100 mM potassium acetate, 30 mM Hepes-KOH, pH 7.4, 2
mM magnesium acetate) for 1 min at 90
 
 
 
C followed by 1 h at 37
 
 
 
C.
 
Cell culture and transfection
 
MDBK cells were cultured in RPMI 1640 medium supplemented with 10%
heat-inactivated bovine FCS, 2 mM glutamine, 1 mM sodium pyruvate,
100 IU/ml penicillin, and 100 
 
 
 
g/ml streptomycin at 37
 
 
 
C with 6.5% CO
 
2
 
.
HeLa cells stably expressing GFP-centrin were maintained using previ-
ously reported procedure (Piel et al., 2000).
To inhibit p160ROCK, cells were treated with 10 
 
 
 
M or 100 
 
 
 
M Y-27632
(provided by Yoshitomi Pharmaceutical Industries) for 15 min to 5 h at 37
 
 
 
C.
The day before transfection, cells were trypsinized, diluted with fresh
medium, and transferred to 24-well plates (10
 
4
 
 cells/well). For transient
transfection of siRNA, Oligofectamine (Invitrogene) was used. 12 
 
 
 
l OPTI-
MEM medium (Invitrogen) and 3 
 
 
 
l Oligofectamine per well was preincu-
bated for 10 min at room temperature. In parallel, 50 
 
 
 
l OPTIMEM me-
dium was mixed with 3 
 
 
 
l siRNA (60 pmole). The two mixtures were
combined and incubated for 20 min at room temperature. After addition of
Figure 7. Centriole behavior in G1 
HeLa cells. Centrioles are shown as in 
Fig. 6 A. G1 HeLa cells recorded as in 
Fig. 6. Time is in minutes. (A) Control 
cell; the MC stays near the cell center. 
(B) Three examples of characteristic be-
haviors of the MC in cells treated with 
100  M of Y-27632: either running 
along the membrane (first two rows) or 
turning around the nucleus (last row). 
Bar, 10  m.
Figure 8. Videomicroscopy analysis of nocodazole 
and cytochalasin effect on centrosomes in cells 
treated with Y-27632. The intercentriolar distance 
and the centriolar speed are plotted over time (gray 
curve, DC speed). (Top graphs) G1 cells were treated 
with 5  M nocodazole (N) and cold for 30 min to 
depolymerize microtubules and then rewarmed at 
37 C and filmed in a medium containing nocodazole 
and 100  M Y-27632. (Bottom graphs) Cells were 
treated with 1 mg/ml CD for 20 min and then filmed 
in the presence of CD and Y-27632. 
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32  l of OPTIMEM medium, the mixture was added to cells. Cells were
usually assayed 48–72 h after transfection. For transient transfection with
KDIA, a cMyc-tagged dominant negative mutant of p160ROCK (Ishizaki et
al., 1997), Lipofectamine Plus reagent (Invitrogen) was used. Cells were
transfected with 0.5  g of DNA by the application of Lipofectamine DNA
coprecipitates in DME (GIBCO BRL). The medium was changed to serum-
free DME at 3 h, and then the cells were cultured for another 12 or 36 h.
Cell synchronization
Mitotic HeLa cells were pooled by mitotic shake off as described in Piel et
al. (2001). They were then replated on fibronectin- and collagen-coated
glass coverslips. After 45 min, unattached cells were gently flushed in or-
der to minimize desynchronization due to the variation of reattachment
time of mitotic cells.
Cell fractionation
MDBK cells or siRNA-transfected HeLa cells were grown on plastic dishes
for 72 h. Whole cell extract were obtained by direct resuspension of cells
in boiling 1% SDS. After sonication, cells extracts were centrifugated 20
min at 100,000 g. The supernatants were further denatured in Laemmli
sample buffer (25 mM Tris, 1% SDS, 10% glycerol, 1% 2-mercaptoethanol)
and boiling.
Centrosome preparation
Centrosomes were purified from calf thymocytes as in Komesli et al.
(1989). Centrosomes were isolated from KE 37 cells as described by
Bornens et al. (1987).
Immunofluorescence microscopy
In all immunofluorescence experiments, antibodies were diluted in PBS sup-
plemented with BSA at 1 mg/ml. Dilution factors are indicated in parentheses.
HeLa cell stably expressing GFP-centrin were grown on coverslips and
washed in PBS before further processing. Cells were generally fixed for 4
min in methanol at –20 C, but for actin staining cells were fixed for 10 min
in 3.7% paraformaldehyde and permeabilized 10 min with PBS containing
0.5% Triton X-100.
The preparations were subsequently washed in PBS, incubated with pri-
mary antibody mouse monoclonal anti– -tubulin antibody clone 2-1
(1:100; Sigma-Aldrich), monoclonal anti-myc antibody (1:100; Invitrogen),
rabbit polyclonal anti–protein N (1:500), or rabbit anti–peptide N1 to N9
(1:100) followed by the appropriate secondary antibody goat anti–mouse
conjugated with fluorescein (1:250; Jackson ImmunoResearch Laboratories),
goat anti–rabbit conjugated with rhodamine (1:250; Jackson ImmunoRe-
search Laboratories), rhodamine phalloidine (1:50; Molecular Probes), or
goat anti–mouse conjugated with Alexa fluor 350 (1:500; Molecular Probes).
Preparations were examined in Leica TCS-SP2 laser-scanning confocal mi-
croscope. Measures of intercentriolar distance and of cell perimeter to sur-
face ratios were performed using IPLab software (Princeton Instruments).
Immuno EM
KE 37–isolated centrosomes were sedimented onto coverslips and pro-
cessed as described in Chevrier et al. (1995) with the exception that tannic
acid treatment of the fixed samples was omitted.
Immunoblot analysis
Gel electrophoresis analysis of each protein fraction was performed in one
dimension according to Laemmli (1970). Proteins were transferred onto
PVDF Immobilon membranes according to Towbin et al. (1979). The mem-
brane was saturated in PBS 0.1% Tween 20 at room temperature for 1 h,
and all subsequent washes and antibody dilutions were performed in this
buffer. The membrane was incubated for 1 h with either rabbit polyclonal N
antibody (1:5,000) or anti–peptide N(1–9) antibodies (1:500). After three 10-
min washes, the membrane was incubated for 1 h with HRP goat anti–rabbit
Figure 9. Synchronization effect of p160 ROCK inhibition on MC movements and abscission. Cells were treated either with 1% DMSO or 
100  M Y-27632 1 h after replating from a mitotic shake off (arrows). Coverslips were then fixed at indicated time points, and the percentages 
of both daughter cell pairs with centriole in the midbody (A) and cells linked by a cytoplasmic bridge (B) were determined. At least 300 cells 
were counted for each percentage determination. Four independent experiments were done. The maximum (max) and the minimum (min) 
values observed are indicated. Percentages do not add up to 100% because centriole localization in the midbody can escape detection and 
because of the statistical error attached to each percentage determination. p160ROCK on centrosomes | Chevrier et al. 817
(1:5,000; Biosource International), washed again, and then developed using
a chemiluminescent ECL kit (Amersham Pharmacia Biotech).
Videomicroscopy
For time-lapse imaging, cells were plated on no. 1 1/2 coverslips. The cov-
erslips were mounted in an opened rose chamber covered by a membrane
permeable to CO2. The microscope stage was equipped with a device en-
abling regulation of temperature and CO2 level. Time-lapse Z sequences
were collected on a Leica DMIRBE microscope controlled by Metamorph
software (Universal Imaging Corp.). This microscope was equipped with a
motorized stage, a 100  1.4 NA Plan Apo Lens, and a cooled CCD cam-
era (MicroMax 5 MHz; Roper Scientific). The final magnification on the
camera chip was 134 nm/pixel (using the 2   2 binning mode of the cam-
era). The illumination device was a 100-W halogen lamp with the potenti-
ometer set under 8V to avoid overillumination. The acquisition time was
400 milliseconds. As a rule, 6–10 sequential z axis images were collected
in 0.5-mm steps every 2 min. In these conditions, cells could enter mitosis
and exit metaphase without any delay compared with cells recorded in
phase–contrast only. Centriole tracking was performed automatically by
Metamorph in maximal intensity projections computed from the original
three-dimensional datasets.
Since Y-27632 is sensitive to light, cells were treated during 1 h with the
drug before time-lapse recording, and the drug-containing medium was re-
newed at 1 h.
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